Evidence map›Paper›PMID 32500173›Full record

Observational studyHeart and vessels2020

Permanent pacemaker implantation and its predictors in patients admitted for complete atrioventricular block: a report from the Tokyo Cardiovascular Care Unit Network multi-center registry.

Shohei Kataoka, Yoshinori Kobayashi, Toshiaki Isogai, Kaoru Tanno, Seiji Fukamizu, Norikazu Watanabe, Akira Ueno, Takeshi Yamamoto, Morimasa Takayama, Ken Nagao

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Heart and vessels, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shohei KataokaTokyo CCU Network Scientific Committee, Tokyo, Japan. shoheikataoka0818@gmail.com.ORCID http://orcid.org/0000-0001-8021-2983
Yoshinori KobayashiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Toshiaki IsogaiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Kaoru TannoTokyo CCU Network Scientific Committee, Tokyo, Japan.
Seiji FukamizuTokyo CCU Network Scientific Committee, Tokyo, Japan.
Norikazu WatanabeTokyo CCU Network Scientific Committee, Tokyo, Japan.
Akira UenoTokyo CCU Network Scientific Committee, Tokyo, Japan.
Takeshi YamamotoTokyo CCU Network Scientific Committee, Tokyo, Japan.
Morimasa TakayamaTokyo CCU Network Scientific Committee, Tokyo, Japan.
Ken NagaoTokyo CCU Network Scientific Committee, Tokyo, Japan.
Shibuya University Network · JPTaoka Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about the permanent pacemaker implantation rate and predictors of permanent pacemaker implantation in patients admitted for complete atrioventricular block (cAVB). The present study was a retrospective analysis based on a multicenter cohort of 797 patients with cAVB (mean age: 79.6 ± 10.7 years; males: 48.4%) registered with the Tokyo Cardiovascular Care Unit Network multicenter registry between 2013 and 2016. Secondary cAVB due to acute coronary syndrome was excluded. The permanent pacemaker implantation rate was 82.9%. Multivariable logistic regression analysis revealed that systolic blood pressure (SBP) > 140 mmHg [odds ratio (OR) 2.10; 95% confidence interval (CI) 1.38-3.22; P < 0.001], male gender (OR 1.63; 95% CI 1.07-2.49; P = 0.023), and left ventricular ejection fraction (LVEF) ≥ 50% (OR 2.19; 95% CI 1.16-2.06; P = 0.016) were predictors of permanent pacemaker implantation while pre-admission β-blocker use (OR 0.28; 95% CI 0.17-0.47; P < 0.001) was associated with a lower risk of permanent pacemaker implantation. Reversible cAVB was not rare in patients admitted for cAVB. Data on SBP on admission, gender, LVEF, and pre-admission β-blocker use may be important for assessing the requirement for permanent pacemaker implantation in the emergency care setting.

Indexed as

Cardiac Pacing, ArtificialPacemaker, ArtificialAgedAged, 80 and overAtrioventricular BlockFemaleHumansMalePatient AdmissionRegistriesRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTokyoTreatment OutcomeBlood pressureComplete atrioventricular blockPacemakerSexβ-blocker

Identifiers

PMID32500173
OpenAlexW3033735223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.